East Coast Diversified Corporation (OTCBB:ECDC) reached up 80.26% in morning trading to $.0137 with 30M shares traded. East Coast Diversified Corporation is a holding corporation with a diversified group of technology companies. Its business portfolio includes businesses offering technology for logistics and asset management, media entertainment technology, transportation safety and class attendance monitoring system and social media applications. East Coast Diversified Corporation (OTCBB:ECDC) announced earlier this week that its subsidiary, Rogue Paper, Inc, and their TV Tune-In platform has experienced nearly 800,000 viewers for their second screen TV applications.
Warrior Girl Corp (PINK: WRGL) reached up 68.75% in morning trading to $.054 with 8M shares traded. Warrior Girl Corp is a holding company for a series of diversified online projects that span B2C operations, financial services, online hosting, web services and social media. WRGL also acts as an incubator for online start-up businesses, providing expertise and funding to development-stage entities in the web arena. New projects are selected which in the view of management have significant upside potential. Warrior Girl Corp (Pink Sheets: WRGL) announced that it has launched "Social Live" a new social media web portal that ventures where Facebook left off.
Cell Therapeutics, Inc. (NASDAQ and MTA: CTIC) reached up 25.23% in morning trading to $1.39 with 15M shares traded. Cell Therapeutics, Inc. is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC) announced today that Pixuvri™ (pixantrone dimaleate) has been granted a positive opinion for conditional approval from the European Medicines Agency's ("EMA") Committee for Medicinal Products for Human Use ("CHMP"). Based on the CHMP's recommendation, CTI expects that a conditional marketing authorization for Pixuvri should be granted by the European Commission within the next few months. CHMP recommended Pixuvri for conditional approval as monotherapy for the treatment of adult patients with multiple relapsed or refractory aggressive non-Hodgkin B-cell lymphomas ("NHL").
For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com
About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.
Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.
PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE
